Immuno-Oncology Research

Articles

Beyond the Checkpoint: What Comes After PD-1?

When the first signals of modern immunotherapy began to emerge a little over a decade ago, many of us realised that oncology was about to change forever. I still remember the sense…

News

Personalised neoantigen vaccine for kidney cancer shows promise in phase 1 study

Personalised neoantigen cancer vaccines (both with and without ipilimumab) elicited anticancer immune responses in nine patients with fully resected clear cell renal cell carcinoma. The investigator-initiated phase 1 trial, published in Nature,…